PDGFRA and neoplasm: We found patients with higher CAF-FAP (FAP+VIM+) at tumor core or lower CAF-C7 (PDGFRA+VIM+) at tumor margin exhibited worse survival (tumor core, n = 154, P = 0.036; tumor margin, n = 148, P = 0.037; Fig. 4l).